2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Sell
21
IMXI Quote, Financials, Valuation and Earnings
Last price:
$11.00
Seasonality move
:
11.46%
Day range:
$10.77 - $11.17
52-week range:
$10.07 - $22.38
Dividend yield:
0%
P/E ratio:
6.53x
P/S ratio:
0.54x
P/B ratio:
2.37x
Volume:
830.3K
Avg. volume:
359.3K
1-year change:
-46.89%
Market cap:
$330.6M
Revenue:
$658.6M
EPS (TTM):
$1.69
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $357.2M | $459.2M | $546.8M | $658.7M | $658.6M | |
| Revenue Growth (YoY) | 11.77% | 28.55% | 19.08% | 20.47% | -0.01% | |
| Cost of Revenues | $238.6M | $350.5M | $417M | $501.1M | $497.2M | |
| Gross Profit | $118.6M | $108.7M | $129.8M | $157.7M | $161.4M | |
| Gross Profit Margin | 33.21% | 23.67% | 23.73% | 23.94% | 24.51% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $54.9M | $30.3M | $34.4M | $47.7M | $47.9M | |
| Other Inc / (Exp) | -- | -$1M | -$3M | -$1.7M | -$4.9M | |
| Operating Expenses | $65.7M | $39.8M | $43.9M | $60.5M | $61.5M | |
| Operating Income | $52.9M | $68.9M | $85.9M | $97.1M | $99.9M | |
| Net Interest Expenses | $6.6M | $4.5M | $5.6M | $10.4M | $11.7M | |
| EBT. Incl. Unusual Items | $46.3M | $63.3M | $77.3M | $85.1M | $83.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $12.5M | $16.5M | $19.9M | $25.5M | $24.5M | |
| Net Income to Company | $33.8M | $46.8M | $57.3M | $59.5M | $58.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $33.8M | $46.8M | $57.3M | $59.5M | $58.8M | |
| Basic EPS (Cont. Ops) | $0.89 | $1.22 | $1.52 | $1.67 | $1.81 | |
| Diluted EPS (Cont. Ops) | $0.88 | $1.20 | $1.48 | $1.63 | $1.79 | |
| Weighted Average Basic Share | $38.1M | $38.5M | $37.7M | $35.6M | $32.4M | |
| Weighted Average Diluted Share | $38.4M | $39.1M | $38.6M | $36.4M | $32.9M | |
| EBITDA | $63.7M | $77.3M | $92.4M | $108.4M | $108.7M | |
| EBIT | $52.9M | $67.9M | $82.9M | $95.5M | $95M | |
| Revenue (Reported) | $357.2M | $459.2M | $546.8M | $658.7M | $658.6M | |
| Operating Income (Reported) | $52.9M | $68.9M | $85.9M | $97.1M | $99.9M | |
| Operating Income (Adjusted) | $52.9M | $67.9M | $82.9M | $95.5M | $95M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $94.6M | $114.7M | $145.4M | $150.4M | $144.3M | |
| Revenue Growth (YoY) | 22.43% | 21.24% | 26.77% | 3.47% | -4.06% | |
| Cost of Revenues | $73.2M | $88.3M | $112.3M | $116M | $112.1M | |
| Gross Profit | $21.3M | $26.4M | $33.1M | $34.4M | $32.2M | |
| Gross Profit Margin | 22.55% | 22.99% | 22.76% | 22.85% | 22.34% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $5.5M | $7.1M | $11.3M | $10M | $11M | |
| Other Inc / (Exp) | -- | -- | -- | -$10K | -$1.5M | |
| Operating Expenses | $7.8M | $9.3M | $14.2M | $14.8M | $16.7M | |
| Operating Income | $13.5M | $17.1M | $18.8M | $19.6M | $15.6M | |
| Net Interest Expenses | $1.3M | $952K | $2.2M | $2.7M | $2.7M | |
| EBT. Incl. Unusual Items | $12.2M | $16.2M | $16.6M | $16.9M | $11.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3.2M | $4.5M | $4.9M | $4.8M | $3.6M | |
| Net Income to Company | $9M | $11.7M | $11.8M | $12.1M | $7.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $9M | $11.7M | $11.8M | $12.1M | $7.8M | |
| Basic EPS (Cont. Ops) | $0.23 | $0.30 | $0.32 | $0.36 | $0.25 | |
| Diluted EPS (Cont. Ops) | $0.23 | $0.30 | $0.31 | $0.35 | $0.25 | |
| Weighted Average Basic Share | $38.2M | $38.4M | $36.5M | $33.7M | $30.6M | |
| Weighted Average Diluted Share | $38.8M | $39.1M | $37.4M | $34.2M | $30.8M | |
| EBITDA | $15.8M | $19.3M | $21.7M | $22.8M | $17.7M | |
| EBIT | $13.5M | $17.1M | $18.8M | $19.6M | $14.1M | |
| Revenue (Reported) | $94.6M | $114.7M | $145.4M | $150.4M | $144.3M | |
| Operating Income (Reported) | $13.5M | $17.1M | $18.8M | $19.6M | $15.6M | |
| Operating Income (Adjusted) | $13.5M | $17.1M | $18.8M | $19.6M | $14.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $374.5M | $479.3M | $577.5M | $663.8M | $652.5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $285.1M | $365.6M | $441M | $504.8M | $493.3M | |
| Gross Profit | $89.4M | $113.7M | $136.5M | $159M | $159.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $22.3M | $31.9M | $38.7M | $46.3M | $47.3M | |
| Other Inc / (Exp) | -- | -- | -- | -$1.7M | -$6.4M | |
| Operating Expenses | $32.7M | $41.2M | $48.9M | $61.1M | $63.4M | |
| Operating Income | $56.7M | $72.5M | $87.6M | $97.9M | $95.9M | |
| Net Interest Expenses | $6M | $4.1M | $6.9M | $10.9M | $11.7M | |
| EBT. Incl. Unusual Items | $50.7M | $67.3M | $77.8M | $85.3M | $77.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $13.6M | $17.8M | $20.3M | $25.4M | $23.3M | |
| Net Income to Company | $37.1M | $49.5M | $57.4M | $59.9M | $54.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $37.1M | $49.5M | $57.4M | $59.9M | $54.5M | |
| Basic EPS (Cont. Ops) | $0.97 | $1.28 | $1.53 | $1.72 | $1.71 | |
| Diluted EPS (Cont. Ops) | $0.97 | $1.26 | $1.50 | $1.67 | $1.69 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $67.2M | $80.8M | $94.8M | $109.4M | $103.6M | |
| EBIT | $56.7M | $71.5M | $84.6M | $96.2M | $89.5M | |
| Revenue (Reported) | $374.5M | $479.3M | $577.5M | $663.8M | $652.5M | |
| Operating Income (Reported) | $56.7M | $72.5M | $87.6M | $97.9M | $95.9M | |
| Operating Income (Adjusted) | $56.7M | $71.5M | $84.6M | $96.2M | $89.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $94.6M | $114.7M | $145.4M | $150.4M | $144.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $73.2M | $88.3M | $112.3M | $116M | $112.1M | |
| Gross Profit | $21.3M | $26.4M | $33.1M | $34.4M | $32.2M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $5.5M | $7.1M | $11.3M | $10M | $11M | |
| Other Inc / (Exp) | -- | -- | -- | -$10K | -$1.5M | |
| Operating Expenses | $7.8M | $9.3M | $14.2M | $14.8M | $16.7M | |
| Operating Income | $13.5M | $17.1M | $18.8M | $19.6M | $15.6M | |
| Net Interest Expenses | $1.3M | $952K | $2.2M | $2.7M | $2.7M | |
| EBT. Incl. Unusual Items | $12.2M | $16.2M | $16.6M | $16.9M | $11.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3.2M | $4.5M | $4.9M | $4.8M | $3.6M | |
| Net Income to Company | $9M | $11.7M | $11.8M | $12.1M | $7.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $9M | $11.7M | $11.8M | $12.1M | $7.8M | |
| Basic EPS (Cont. Ops) | $0.23 | $0.30 | $0.32 | $0.36 | $0.25 | |
| Diluted EPS (Cont. Ops) | $0.23 | $0.30 | $0.31 | $0.35 | $0.25 | |
| Weighted Average Basic Share | $38.2M | $38.4M | $36.5M | $33.7M | $30.6M | |
| Weighted Average Diluted Share | $38.8M | $39.1M | $37.4M | $34.2M | $30.8M | |
| EBITDA | $15.8M | $19.3M | $21.7M | $22.8M | $17.7M | |
| EBIT | $13.5M | $17.1M | $18.8M | $19.6M | $14.1M | |
| Revenue (Reported) | $94.6M | $114.7M | $145.4M | $150.4M | $144.3M | |
| Operating Income (Reported) | $13.5M | $17.1M | $18.8M | $19.6M | $15.6M | |
| Operating Income (Adjusted) | $13.5M | $17.1M | $18.8M | $19.6M | $14.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $74.9M | $132.5M | $149.5M | $239.2M | $130.5M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $55M | $67.3M | $129.8M | $155.2M | $107.1M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $56.1M | $62M | $97.1M | $34.3M | $56.2M | |
| Other Current Assets | $218K | $1M | $4.7M | $2.6M | $1.9M | |
| Total Current Assets | $186.7M | $263.5M | $382.4M | $432.9M | $297.8M | |
| Property Plant And Equipment | $13M | $17.9M | $52.9M | $60.1M | $68.9M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $36.3M | $36.3M | $49.8M | $54M | $55.2M | |
| Other Intangibles | $20.4M | $15.4M | $19.8M | $18.1M | $26.8M | |
| Other Long-Term Assets | $1.4M | $5.8M | $4.7M | $5.4M | $7.8M | |
| Total Assets | $259.5M | $340.5M | $512.1M | $576.8M | $462.4M | |
| Accounts Payable | $12.8M | $23.2M | $25.7M | $36.5M | $19.5M | |
| Accrued Expenses | $5.9M | $9.2M | $10.6M | $14.4M | $14.8M | |
| Current Portion Of Long-Term Debt | $7M | $3.9M | $5M | $7.2M | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | $5.3M | $5M | $6.5M | |
| Other Current Liabilities | -- | -- | $1.3M | $2M | $2.4M | |
| Total Current Liabilities | $83.9M | $116.9M | $184.8M | $223.4M | $152M | |
| Long-Term Debt | $80.6M | $79.2M | $150.2M | $181.1M | $156.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $165.2M | $197.5M | $362.2M | $427.8M | $327.5M | |
| Common Stock | $4K | $4K | $4K | $4K | $4K | |
| Other Common Equity Adj | -$13K | -$76K | -$142K | $262K | -$1.4M | |
| Common Equity | $94.3M | $143M | $149.9M | $149M | $134.9M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $94.3M | $143M | $149.9M | $149M | $134.9M | |
| Total Liabilities and Equity | $259.5M | $340.5M | $512.1M | $576.8M | $462.4M | |
| Cash and Short Terms | $74.9M | $132.5M | $149.5M | $239.2M | $130.5M | |
| Total Debt | $87.6M | $83.1M | $155.2M | $188.2M | $156.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $55.1M | $157.2M | $85.5M | $218.8M | $151.8M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $66.8M | $86.4M | $102.6M | $149.1M | $131M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $92.1M | $20.2M | $110.6M | $29.1M | $39.9M | |
| Other Current Assets | $208K | $500K | $4.2M | $2.6M | $1.3M | |
| Total Current Assets | $214.6M | $265.2M | $304.4M | $401.8M | $325.9M | |
| Property Plant And Equipment | $13.8M | $26.1M | $51.5M | $63.6M | $70.3M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $36.3M | $36.3M | $48.6M | $54M | $55.2M | |
| Other Intangibles | $19.1M | $14.4M | $18.7M | $17.1M | $26.1M | |
| Other Long-Term Assets | $3M | $5.8M | $5M | $5.4M | $7.4M | |
| Total Assets | $286.8M | $349.7M | $430.8M | $548.7M | $490.6M | |
| Accounts Payable | $11.2M | $17.2M | $21.3M | $40.3M | $23.4M | |
| Accrued Expenses | $6.2M | $6.7M | $9.4M | $13.5M | $13.9M | |
| Current Portion Of Long-Term Debt | $7.7M | $3.9M | $5.5M | $7.7M | -- | |
| Current Portion Of Capital Lease Obligations | -- | $1.5M | $4.8M | $5.4M | $6.4M | |
| Other Current Liabilities | -- | -- | $1.3M | $2M | $2.4M | |
| Total Current Liabilities | $87.5M | $113.7M | $156.4M | $238.6M | $186.5M | |
| Long-Term Debt | $93.2M | $78.2M | $93.7M | $150.5M | $147.4M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $181.2M | $197M | $274.9M | $410.5M | $351.3M | |
| Common Stock | $4K | $4K | $4K | $4K | $4K | |
| Other Common Equity Adj | -$17K | $36K | $40K | $117K | -$1.1M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $105.6M | $152.7M | $155.9M | $138.2M | $139.2M | |
| Total Liabilities and Equity | $286.8M | $349.7M | $430.8M | $548.7M | $490.6M | |
| Cash and Short Terms | $55.1M | $157.2M | $85.5M | $218.8M | $151.8M | |
| Total Debt | $100.9M | $82.1M | $99.2M | $158.2M | $147.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $33.8M | $46.8M | $57.3M | $59.5M | $58.8M | |
| Depreciation & Amoritzation | $10.8M | $9.5M | $9.5M | $12.9M | $13.6M | |
| Stock-Based Compensation | $3.2M | $4.6M | $7.1M | $8.1M | $7M | |
| Change in Accounts Receivable | -$17.1M | -$13.8M | -$48.6M | -$29.2M | $41.6M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$880K | $78.1M | $15.2M | $143.5M | $53.1M | |
| Capital Expenditures | $4.1M | $10.6M | $12.2M | $12.8M | $30M | |
| Cash Acquisitions | -- | -$185K | -$356K | -$5.5M | -$13.9M | |
| Cash From Investing | -$4.1M | -$10.8M | -$12.5M | -$18.3M | -$43.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $40.2M | $76M | $38M | $3B | |
| Long-Term Debt Repaid | -$7.7M | -$44.2M | -$4.4M | -$5.5M | -$3.1B | |
| Repurchase of Common Stock | -- | -$5.6M | -$53.7M | -$66.3M | -$75.1M | |
| Other Financing Activities | -- | -$3.8M | -$5.5M | -$4.7M | -$5.5M | |
| Cash From Financing | -$6.2M | -$9.6M | $14.1M | -$37.1M | -$114.2M | |
| Beginning Cash (CF) | $86.1M | $74.9M | $132.5M | $149.5M | $239.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$11.1M | $57.7M | $16.7M | $88.1M | -$105.1M | |
| Ending Cash (CF) | $74.9M | $132.5M | $149.5M | $239.2M | $130.5M | |
| Levered Free Cash Flow | -$4.9M | $67.5M | $3M | $130.7M | $23.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $9M | $11.7M | $11.8M | $12.1M | $7.8M | |
| Depreciation & Amoritzation | $2.3M | $2.2M | $2.9M | $3.2M | $3.6M | |
| Stock-Based Compensation | $896K | $1.3M | $1.7M | $2.2M | $2.1M | |
| Change in Accounts Receivable | -$11.9M | -$19.5M | $26.4M | $4.5M | -$25.9M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$32.4M | $33.3M | $1.2M | $48.2M | $41.3M | |
| Capital Expenditures | $1.9M | $4.3M | $2.1M | $13.5M | $5.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.9M | -$4.3M | -$2.1M | -$13.5M | -$5.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $15M | -- | -- | -- | $1.9B | |
| Long-Term Debt Repaid | -$1.9M | -$1.1M | -$56.1M | -$30.1M | -$1.9B | |
| Repurchase of Common Stock | -- | -$3.6M | -$7.6M | -$23.4M | -$5M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $14.5M | -$4.4M | -$63.8M | -$55.1M | -$15.1M | |
| Beginning Cash (CF) | $74.9M | $132.5M | $149.5M | $239.2M | $130.5M | |
| Foreign Exchange Rate Adjustment | -$3K | $229K | $710K | -$100K | $437K | |
| Additions / Reductions | -$19.8M | $24.5M | -$64.8M | -$20.3M | $20.8M | |
| Ending Cash (CF) | $55.1M | $157.2M | $85.5M | $218.8M | $151.8M | |
| Levered Free Cash Flow | -$34.3M | $29M | -$961K | $34.8M | $36M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $37.1M | $49.5M | $57.4M | $59.9M | $54.5M | |
| Depreciation & Amoritzation | $10.5M | $9.3M | $10.2M | $13.2M | $14M | |
| Stock-Based Compensation | $3.4M | $5M | $7.5M | $8.6M | $7M | |
| Change in Accounts Receivable | -$29.8M | -$21.5M | -$2.7M | -$51.2M | $11.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$52.1M | $143.8M | -$17M | $190.6M | $46.1M | |
| Capital Expenditures | $5.1M | $13M | $10M | $24.2M | $21.8M | |
| Cash Acquisitions | -- | -$185K | -$356K | -$5.5M | -$13.9M | |
| Cash From Investing | -$5.1M | -$13.2M | -$10.3M | -$29.6M | -$35.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $15M | -- | -- | $38M | $4.9B | |
| Long-Term Debt Repaid | -$7.7M | -$43.4M | -$59.4M | $20.5M | -$4.9B | |
| Repurchase of Common Stock | -- | -$9.2M | -$57.7M | -$82.1M | -$56.7M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $10.3M | -$28.6M | -$45.3M | -$28.4M | -$74.3M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$46.9M | $102.1M | -$72.6M | $132.6M | -$63.9M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$57.2M | $130.8M | -$26.9M | $166.4M | $24.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $9M | $11.7M | $11.8M | $12.1M | $7.8M | |
| Depreciation & Amoritzation | $2.3M | $2.2M | $2.9M | $3.2M | $3.6M | |
| Stock-Based Compensation | $896K | $1.3M | $1.7M | $2.2M | $2.1M | |
| Change in Accounts Receivable | -$11.9M | -$19.5M | $26.4M | $4.5M | -$25.9M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$32.4M | $33.3M | $1.2M | $48.2M | $41.3M | |
| Capital Expenditures | $1.9M | $4.3M | $2.1M | $13.5M | $5.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.9M | -$4.3M | -$2.1M | -$13.5M | -$5.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $15M | -- | -- | -- | $1.9B | |
| Long-Term Debt Repaid | -$1.9M | -$1.1M | -$56.1M | -$30.1M | -$1.9B | |
| Repurchase of Common Stock | -- | -$3.6M | -$7.6M | -$23.4M | -$5M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $14.5M | -$4.4M | -$63.8M | -$55.1M | -$15.1M | |
| Beginning Cash (CF) | $74.9M | $132.5M | $149.5M | $239.2M | $130.5M | |
| Foreign Exchange Rate Adjustment | -$3K | $229K | $710K | -$100K | $437K | |
| Additions / Reductions | -$19.8M | $24.5M | -$64.8M | -$20.3M | $20.8M | |
| Ending Cash (CF) | $55.1M | $157.2M | $85.5M | $218.8M | $151.8M | |
| Levered Free Cash Flow | -$34.3M | $29M | -$961K | $34.8M | $36M | |
Get IMXI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
IMXI
Sector
P/E ratio
6.53x
11.72x
PEG ratio
5.45x
0.39x
P/B ratio
2.37x
1.05x
Price / LTM sales
0.54x
2.54x
Growth Metrics
IMXI
Sector
Revenue growth
-4.06%
5.1%
Earnings growth
-28.57%
2.96%
Revenue (5-year growth)
15.56%
5.18%
Earnings forecast
$0.42
$0.56
Profitability
IMXI
Sector
Profitability FY 2024
$161.4M
$138.7M
Return on invested capital
18.06%
5.31%
Return on assets
10.5%
0.97%
Return on equity
39.1%
9.25%
Earnings Date
Last Earnings Date
May
7
Next Earnings Date
Aug
7
Estimated Next Earnings Date
Aug
6
Balance Sheet
IMXI
Sector
Total cash
$151.8M
$470.2M
Short term investments
--
$233.7M
Total assets
$462.4M
$4B
Long term debt
$147.4M
$296.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Where Will Dell Stock Be in 5 Years?
So you’re looking at Dell (NASDAQ: DELL) and wondering, “Is…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
